This approach minimises gastrointestinal side effects
It works by targeting three pathways as opposed to one for semaglutide and two for tirzepatide, creating a powerful effect on appetite and blood sugar regulation
A clinician will review: Medical history: This includes your weight over the years, stage of menopause, sleep habits, stress levels, and other medications
GLP-1 increases insulin release, decreases glucagon, slows stomach emptying, and enhances satiety to control blood sugar
Effect of liraglutide therapy on liver fat content in patients with inadequately controlled type 2 diabetes
During T2D development, chronic overnutrition interferes with insulin signaling leading to decreases in insulin sensitivity